Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02288494
Other study ID # CHU-0204
Secondary ID
Status Active, not recruiting
Phase N/A
First received September 12, 2014
Last updated November 7, 2014
Start date October 2013
Est. completion date November 2014

Study information

Verified date November 2014
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Observational

Clinical Trial Summary

The primary purpose was to describe the acid base balance of ICU patients with severe hypoalbuminemia using Stewart's approach for acid base disorders, before and after an human albumin perfusion.


Description:

Prospective study, for ICU patient with severe hypoalbuminemia < 20g/L, determining biological parameters from Stewart approach for acid base disorders (pH, SIDe, SIDa, SIG, Atot, PaCO2) before, and at 1hour, 2hours and 24 hours after a 200mL 20% human albumin perfusion (the consensus conference ANAES of 1995 recommands to correct hypoalbuminemia below 20g/L).

Clinical parameters (respiratory, haemodynamic, neurologic) were also collected at the same times.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 100
Est. completion date November 2014
Est. primary completion date November 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- serum albuminemia < 20g/L

- adult ICU patient

- Arterial line

Exclusion Criteria:

- albumin allergy

- pregnancy

- congestive heart failure

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
stewart approach
Prospective study, for ICU patient with severe hypoalbuminemia < 20g/L, determining biological parameters from Stewart approach for acid base disorders (pH, SIDe, SIDa, SIG, Atot, PaCO2) before, and at 1hour, 2hours and 24 hours after a 200mL 20% human al Clinical parameters (respiratory, haemodynamic, neurologic) were also collected at the same times.

Locations

Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in pH and independent pH determinants using Stewart approach at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. No
Secondary changes in neurologic parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. No
Secondary changes in hemodynamic parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. No
Secondary changes in respiratory parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05050851 - Nutritional Parameters and Other Risk Factors Affecting Severity of Pneumonia in Children Under Five Years in Upper Egypt
Terminated NCT00529633 - The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients Phase 3
Active, not recruiting NCT03675906 - The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria
Terminated NCT04071041 - Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia. Phase 3
Completed NCT03569410 - The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients N/A
Terminated NCT02457702 - Mitochondrial Function in Patients With Severe Liver Disease N/A
Completed NCT02765061 - Hyponatremia and Hypoalbuminemia is Morbimortality Predictors in Coronary Artery Bypass Graft Surgery N/A
Completed NCT03167645 - SUbstition of PERioperative Albumin Deficiency Disorders Phase 4
Recruiting NCT05797649 - Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis
Completed NCT01822600 - The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia Phase 4
Completed NCT01542749 - Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer N/A
Completed NCT00723762 - Valproic Acid-associated Hypoalbuminemia in Medically Fragile Patients N/A
Completed NCT00561093 - Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase 3
Completed NCT04046263 - Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients Phase 4
Completed NCT00597025 - Impact of Providing High Protein Bar to Dialysis Patients With Low Serum Albumin N/A
Completed NCT06355479 - A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia Phase 3